WILFRID S LIN RPH
Prescription History 1346478708
Pharmacist in Milwaukie, OR
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for WILFRID S LIN RPH, an active Pharmacist specialist practicing in Milwaukie, OR. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 95 documented patient claims. Among these therapy options, the most frequently utilized medication is Arexvy, which accounts for 37 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OR PrescribersVs. OR Avg |
|---|---|---|---|
| ArexvyRsvpref3 Antigen/As01e/Pf | 37 | $257.39▼ below OR avg | ≈ Typical |
About Arexvy: This vaccine is used to prevent infection by the respiratory syncytial virus (RSV). Show more ▾ Some brands may also be given during the third trimester of pregnancy to help prevent RSV in the newborn baby. RSV can cause serious illness, especially in older adults with certain health problems (such as heart disease, lung disease) and infants. It works by causing the body to produce its own protection (antibodies) against the virus. Vaccines may not fully protect everyone who receives them. In 2024, this provider wrote 37 Medicare prescriptions for Arexvy, about the same volume as the typical Oregon prescriber of this medication (34.1). Medicare paid an average of $257.39 per fill, versus $276.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OR average for this medication. 37 30-Day Fills standardized to 30-day supplies 37 Days of Medication total across all patients in 2024 | |||
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 31 | $53.66▼ below OR avg | ≈ Typical |
About Boostrix Tdap: This vaccine is used to keep up protection (immunity) against diphtheria, tetanus (lockjaw) and pertussis (whooping cough) in children and adults who have been vaccinated for these diseases in the past. Show more ▾ It may also be given during the third trimester of pregnancy to help prevent pertussis in the newborn baby. Vaccination is the best way to protect against these life-threatening diseases. Vaccines work by causing the body to produce its own protection (antibodies). Booster doses are needed to keep up immunity because antibody levels may become too low over time to provide the needed protection. In 2024, this provider wrote 31 Medicare prescriptions for Boostrix Tdap, about 1.2 times the volume of the typical Oregon prescriber of this medication (26.7). Medicare paid an average of $53.66 per fill, versus $62.53 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OR average for this medication. 31 30-Day Fills standardized to 30-day supplies 31 Days of Medication total across all patients in 2024 | |||
| ShingrixVaricella-Zoster Ge/As01b/Pf | 27 | $183.99▼ below OR avg | ▼ Less than typical |
About Shingrix: This vaccine is used by adults to prevent zoster (shingles). Show more ▾ Zoster is caused by the same virus that causes chickenpox. After you have been infected with chickenpox (usually in childhood), the virus can live in your body's nerve roots in an inactive form. For reasons that are not fully understood, the virus may become active again. This causes shingles with symptoms of rash, blisters, and pain. This vaccine works by boosting the body's natural defense (immunity) against the zoster virus so that symptoms of shingles do not develop. It should not be used for treating active shingles, nerve pain caused by shingles, or for the prevention of chickenpox. Vaccines may not fully protect everyone who receives them. This vaccine should not be used by children. In 2024, this provider wrote 27 Medicare prescriptions for Shingrix, about 68% of the volume of the typical Oregon prescriber of this medication (39.9). Medicare paid an average of $183.99 per fill, versus $200.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OR average for this medication. 27 30-Day Fills standardized to 30-day supplies 27 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for WILFRID S LIN RPH is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pharmacist prescribing approach at this Milwaukie, OR practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OR prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
